Coronary Restenosis after Drug-Eluting Stent Implantation in Diabetic Patients

다국어 초록 (Multilingual Abstract)

In the era of drug-eluting stents (DESs), the angiographic rates of restenosis at later months have been dramaticallyreduced, but these rates have been less prominently reduced in diabetic patients. The rate of coronaryrestenosis is still higher in diabetic patients, when compared with non-diabetic patients, and even after DESimplantation. Diabetes remains a significant predictor of coronary restenosis even in the era of DES, and especiallyin cases having a small baseline vessel size, a small post-PCI vessel size and a longer stent length. The use ofthe sirolimus-eluting stent in diabetic patients has been associated with a decreased rate of restenosis, and thissuggests a reduced risk of target lesion revascularization. Diabetes still remains a major risk factor for coronaryrestenosis after DES implantation, and so aggressive risk factor management with the concomitant pharmacotherapyshould be done to reduce the risk of coronary restenosis. (Korean Circulation J 2006;36:1-7)

참고문헌 (Reference)

1 "Vessel size and long-term outcome after coronarystent placement" 98 : 1875-1880, 1998

2 "Upregulation ofbasement membrane-degrading metalloproteinase secretion afterballoon injury of pig carotid arteries" 79 : 1177-1187, 1996

3 "The microtubule-affectingdrug paclitaxel has antiangiogenic activity" 2 : 1843-1849, 1996

4 "The inhibition of neointimalhyperplasia by combination of external radiation and paclitaxelin a rat carotid injury model" 30 : 758-766, 2000

5 "The effects of local delivery ofpaclitaxel nanoparticle on porcine coronary stent restenosis" 30 : 208-220, 2000

6 "The clinical effects of drugelutingstents for the treatment of coronary in-stent restenosis" 35 : 443-447, 2005

7 "Taxol inhibits neointimalsmooth muscle cell accumulation after angioplasty in the rat" 95 : 1869-1876, 1995

8 "TOR of the cell cycle:are there important implicationsfor diabetics in the era of the drug-eluting stent" 61 : 233-236, 2004

9 "Stented segmentlength as an independent predictor of restenosis" 34 : 651-659, 1999

10 "Status of the coronaryarteries at necropsy in diabetes mellitus with onset afterage 30 years:analysis of 229 diabetic patients with and withoutclinical evidence of coronary heart disease and comparison to183 control subjects" 69 : 498-506, 1980

11 "Sirolimus-eluting stentsversus standard stents in patients with stenosis in a native coronaryartery" 349 : 1315-1323, 2003

12 "Sirolimus-eluting stentsversus standard stents in patients with stenosis in a native coronaryartery" 349 : 1315-1523, 2003

13 "Sirolimus-eluting coronary stents" 346 : 1770-1771, 2002

14 "Riskstratification for long-term outcome after elective coronary angioplasty:a multivariate analysis of 5,000 patients" 24 : 74-80, 1994

15 "Recent advances in our understanding ofinsulin action and insulin resistance" 24 : 588-597, 2001

16 "Rapamycin-FKBPinhibits cell cycle regulators of proliferation in vascular smoothmuscle cells" 76 : 412-417, 1995

17 "Proto-oncogeneexpression in rabbit aorta after wall injury:first marker of thecellular process leading to restenosis after angioplasty" 13 : 556-559, 1992

18 "Procoagulantinflammatory responses of monocytes after direct balloonangioplasty in acute myocardial infarction" 82 : 938-942, 1998

19 "Preventative effects of rosiglitazoneon restenosis after coronary stent implantation in patientswith type 2 diabetes" 27 : 2654-2660, 2004

20 "Preliminary observationsregarding angiographic pattern of restenosis after rapamycin-eluting stent implantation" 107 : 2178-2180, 2003

21 "Predictors of restenosis aftercoronary stent implantation" 31 : 1291-1298, 1998

22 "Predictors of angiographicrestenosis after coronary intervention in patients withdiabetes mellitus" 145 : 1013-1021, 2003

23 "Potential mechanismspromoting restenosis in diabetic patients" 27 : 528-535, 1996

24 "Percutaneous coronary revascularizationof diabetic patients in the era of drug-eluting stents" 6 : 48-58, 2005

25 "Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients" 353 : 663-670, 2005

26 "Outcomes with thepolymer-based paclitaxel-eluting TAXUS stent in patients withdiabetes mellitus:the TAXUS-IV trial" 45 : 1172-1179, 2005

27 "Outcomes in patientswith diabetes mellitus undergoing percutaneous coronary interventionin the current era:a report from the Prevention of REStenosiswith Tranilast and its Outcomes(PRESTO)trial" 109 : 476-480, 2004

28 "Oral everolimus reducesadventitial cell activation and neointima formation in ballooninjuredrat carotid artery" 34 : 983-991, 2004

29 "Optimal glycemic controlis associated with a lower rate of target vessel revascularizationin treated type II diabetic patients undergoing elective percutaneouscoronary intervention" 43 : 8-14, 2004

30 "Neointimaltissue response at sites of coronary stenting in humans:macroscopic,histological,and immunohistochemical analyses" 98 : 224-233, 1998

31 "Morphologicalpredictors of restenosis after coronary stenting inhumans" 105 : 2974-2980, 2002

32 "Midterm angiographicoutcome of single-vessel intracoronary stent placement in diabeticversus nondiabetic patients:a matched comparative study" 136 : 150-155, 1998

33 "Long-term clinical andangiographic results of coronary stenting in diabetic patients" 31 : 24-30, 2001

34 "Leptin enhances the calcification of vascular cells:artery wallas a target of leptin" 88 : 954-960, 2001

35 "Insulin resistance,hyperleptinemia and endothelialdysfunction in coronary restenosis" 5 : 160-164, 2005

36 "Insulin resistance differentiallyaffects the PI 3-kinase- and MAP kinase-mediated signalingin human muscle" 105 : 311-320, 2000

37 "Influence of treatment modality on angiographic outcome aftercoronary stenting in diabetic patients:a controlled study" 35 : 1554-1559, 2000

38 "Influence of lesion length on restenosis after coronarystent placement" 83 : 1617-1622, 1999

39 "Influence of diabetesmellitus on early and late outcome after percutaneous transluminalcoronary angioplasty" 91 : 979-989, 1995

40 "Increased secretion of insulinduring oral glucose tolerance test can be a predictor ofstent restenosis in nondiabetic patients" 58 : 306-312, 2003

41 "Increased restenosis indiabetes mellitus after coronary interventions is due to exaggeratedintimal hyperplasia:a serial intravascular ultrasound study" 95 : 1366-1369, 1997

42 "Increased restenosis indiabetes mellitus after coronary interventions is due to exaggeratedintimal hyperplasia:a serial intravascular ultrasound study" 95 : 1366-1369, 1997

43 "In-stent restenosis:contributions of inflammatory responses andarterial injury to neointimal hyperplasia" 31 : 224-230, 1998

44 "Hyperinsulinemia duringoral glucose tolerance test is associated with increased neointimaltissue proliferation after coronary stent implantation innondiabetic patients:a serial intravascular ultrasound study" 36 : 731-738, 2000

45 "Hyperglycemia and cardiovascular disease in type 2diabetes" 48 : 937-942, 1999

46 "Five-year angiographicfollow-up of factors associated with progression of coronaryartery disease in the Coronary Artery Surgery Study(CASS)" 22 : 1141-54, 1993

47 "Expression of tissue inhibitor of matrix metalloproteinases1 by use of an adenoviral vector inhibits smooth musclecell migration and reduces neointimal hyperplasia in the ratmodel of vascular balloon injury" 99 : 3199-3205, 1999

48 "Effectsof ramipril on cardiovascular and microvascular outcomesin people with diabetes mellitus:results of the HOPE study andMICRO-HOPE substudy" 355 : 253-259, 2000

49 "Effects of clopidogrel in addition to aspirin in patients with acutecoronary syndromes without ST-segment elevation" 345 : 494-502, 2001

50 "Effect of paclitaxel localdelivery on neointimal formation after endothelial denudation ofthe rat carotid artery" 30 : 198-207, 2000

51 "Early and midtermresults of coronary stenting in the diabetic patient" 29 : 292-297, 1999

52 "Drug-eluting stents in vascular intervention" 361 : 247-249, 2003

53 "Drug eluting stent and percutaneous coronary intervention" 33 : 857-860, 2003

54 "Diabetes,otherrisk factors,and 12-yr cardiovascular mortality for men screenedin the Multiple Risk Factor Intervention Trial" 16 : 434-434, 1993

55 "Diabetes mellitus and theclinical and angiographic outcome after coronary stent placement" 32 : 1866-1873, 1998

56 "Diabetes is still a risk factor for restenosisafter drug-eluting stent in coronary arteries" 27 : 1840-1841, 2004

57 "Diabetes and atherosclerosis:epidemiology,pathophysiology,and management" 287 : 2570-2581, 2002

58 "D allele of the angiotensinI-converting enzyme is a major risk factor for restenosis aftercoronary stenting" 96 : 56-60, 1997

59 "Coronary angioplasty in diabetic patients:The National Heart,Lung,and Blood Institute Percutaneous Transluminal CoronaryAngioplasty Registry" 94 : 1818-1825, 1996

60 "Clinical and quantitativecoronary angiographic predictors of coronary restenosis:a comparativeanalysis from the balloon-to-stent era" 38 : 645-652, 2001

61 "Clinical and angiographicpredictors of restenosis after stent deployment in diabeticpatients" 109 : 867-873, 2004

62 "Angiographic patternsof in-stent restenosis:classification and implications for longtermoutcome" 100 : 1872-1878, 1999

63 "A randomized comparisonof a sirolimus-eluting stent with a standard stent forcoronary revascularization" 346 : 1773-1780, 2002

64 "A polymer-based, paclitaxelelutingstent in patients with coronary artery disease" 36 : 1-7, 2006